Avadel Pharmaceuticals
  • Recent News
  • Investors
  • About
    • Overview
    • Leadership
    • Board of Directors
    • Business Development
    • Corporate Responsibility
  • Research
    • Clinical Trials
  • Contact Us
  • Call Today
  • Email Us
  • Our Map
    • Avadel Pharmaceuticals
    • 636.449.1830
    • About
      • Overview
      • Leadership
      • Board of Directors
      • Business Development
      • Corporate Responsibility
    • Research
      • Clinical Trials
    • Contact Us
    • Investors
      Careers
636.449.1830
Home > Research Pipeline > Innovative Technologies > Medusa™

Medusa™

Medusa™ is a hydrogel depot technology that allows an improved delivery, thus resulting in stronger treatment adherence. This innovative approach enables the modified and controlled delivery of drug between one day and one week of drugs without altering the underlying compound. Medusa™ is particularly suited to the development of subcutaneously administered drug formulations.

  • Medusa™ has the potential to provide:
  • Improved dosing for biologic drugs with established markets
  • Product differentiation e.g. improvement of pharmacokinetic (and potentially pharmacodynamics) parameters
  • Protection of market position through product differentiation and/or patent extension

Avadel is actively seeking partnership opportunities for Medusa™.
Please contact our business development team for more information.

Research Pipeline

  • Innovative Technologies
    • Micropump®
    • LiquiTime®
    • Trigger Lock™
    • Medusa™

Contact Avadel Pharmaceuticals Today

Avadel Pharmaceuticals

Helpful Links Site Map | Privacy Policy | Terms and Conditions

  • Overview
  • News & Events
  • Careers
  • Investors
  • Contact Us
16640 Chesterfield Grove Road,
Suite 200,
Saint Louis, MO 63005 |  View Map [+]
https://www.avadel.com/
Site Map | Privacy Policy
http://www.avadel.com

© COPYRIGHT AVADEL PHARMACEUTICALS, PLC. ALL RIGHTS RESERVED

0117 AVL WBST TECH MDSA_KP2

Powered by Scorpion